These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 37816193)

  • 1. The Therapeutic Potential of Targeting Ferroptosis in the Treatment of Mitochondrial Cardiomyopathies and Heart Failure.
    Cantrell AC; Zeng H; Chen JX
    J Cardiovasc Pharmacol; 2024 Jan; 83(1):23-32. PubMed ID: 37816193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferrostatin-1 specifically targets mitochondrial iron-sulfur clusters and aconitase to improve cardiac function in Sirtuin 3 cardiomyocyte knockout mice.
    Cantrell AC; Besanson J; Williams Q; Hoang N; Edwards K; Bishop GR; Chen Y; Zeng H; Chen JX
    J Mol Cell Cardiol; 2024 Jul; 192():36-47. PubMed ID: 38734062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting ferroptosis in the maintenance of mitochondrial homeostasis in the realm of septic cardiomyopathy.
    Ye H; Hu H; Zhou X; Dong M; Ren J
    Curr Opin Pharmacol; 2024 Feb; 74():102430. PubMed ID: 38237386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis in Friedreich's Ataxia: A Metal-Induced Neurodegenerative Disease.
    La Rosa P; Petrillo S; Fiorenza MT; Bertini ES; Piemonte F
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33202971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy.
    Stram AR; Wagner GR; Fogler BD; Pride PM; Hirschey MD; Payne RM
    PLoS One; 2017; 12(5):e0178354. PubMed ID: 28542596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis as a target for protection against cardiomyopathy.
    Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis and its role in cardiomyopathy.
    Li D; Pi W; Sun Z; Liu X; Jiang J
    Biomed Pharmacother; 2022 Sep; 153():113279. PubMed ID: 35738177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis.
    Fang X; Cai Z; Wang H; Han D; Cheng Q; Zhang P; Gao F; Yu Y; Song Z; Wu Q; An P; Huang S; Pan J; Chen HZ; Chen J; Linkermann A; Min J; Wang F
    Circ Res; 2020 Jul; 127(4):486-501. PubMed ID: 32349646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of the Ferroptosis Hallmarks in Friedreich's Ataxia.
    Turchi R; Faraonio R; Lettieri-Barbato D; Aquilano K
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33126466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptotic Cell Death: New Regulatory Mechanisms for Metabolic Diseases.
    Le Y; Zhang Z; Wang C; Lu D
    Endocr Metab Immune Disord Drug Targets; 2021; 21(5):785-800. PubMed ID: 32735532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy.
    Sun H; Chen D; Xin W; Ren L; Li Q; Han X
    Front Pharmacol; 2023; 14():1146651. PubMed ID: 37138856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis in mitochondrial cardiomyopathy.
    Ahola S; Langer T
    Trends Cell Biol; 2024 Feb; 34(2):150-160. PubMed ID: 37419738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ironing out the details: ferroptosis and its relevance to diabetic cardiomyopathy.
    Gawargi FI; Mishra PK
    Am J Physiol Regul Integr Comp Physiol; 2023 Dec; 325(6):R665-R681. PubMed ID: 37746707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis inhibitor improves cardiac function more effectively than inhibitors of apoptosis and necroptosis through cardiac mitochondrial protection in rats with iron-overloaded cardiomyopathy.
    Kumfu S; Sripetchwandee J; Thonusin C; Sumneang N; Maneechote C; Arunsak B; Chunchai T; Oo TT; Kongkaew A; Chattipakorn SC; Chattipakorn N
    Toxicol Appl Pharmacol; 2023 Nov; 479():116727. PubMed ID: 37863361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis as a novel therapeutic target for cardiovascular disease.
    Wu X; Li Y; Zhang S; Zhou X
    Theranostics; 2021; 11(7):3052-3059. PubMed ID: 33537073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of iron homeostasis in the heart : Heart failure, cardiomyopathy, and ischemia-reperfusion injury.
    Ying H; Shen Z; Wang J; Zhou B
    Herz; 2022 Apr; 47(2):141-149. PubMed ID: 33978777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
    Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB
    J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of impaired mitochondrial homeostasis and NAD
    Chiang S; Braidy N; Maleki S; Lal S; Richardson DR; Huang ML
    Redox Biol; 2021 Oct; 46():102038. PubMed ID: 34416478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes.
    Sumneang N; Siri-Angkul N; Kumfu S; Chattipakorn SC; Chattipakorn N
    Arch Biochem Biophys; 2020 Feb; 680():108241. PubMed ID: 31891670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ferroptosis by natural products in pathophysiological conditions.
    Zheng D; Jin S; Liu PS; Ye J; Xie X
    Arch Toxicol; 2024 Oct; 98(10):3191-3208. PubMed ID: 38987487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.